BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 24760754)

  • 21. Midkine prevents ventricular remodeling and improves long-term survival after myocardial infarction.
    Takenaka H; Horiba M; Ishiguro H; Sumida A; Hojo M; Usui A; Akita T; Sakuma S; Ueda Y; Kodama I; Kadomatsu K
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H462-9. PubMed ID: 19060126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.
    Tang J; Wang J; Kong X; Yang J; Guo L; Zheng F; Zhang L; Huang Y; Wan Y
    Exp Cell Res; 2009 Dec; 315(20):3521-31. PubMed ID: 19800880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
    Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
    Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis.
    Ikeda S; Ushio-Fukai M; Zuo L; Tojo T; Dikalov S; Patrushev NA; Alexander RW
    Circ Res; 2005 Mar; 96(4):467-75. PubMed ID: 15692085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.
    Rengo G; Cannavo A; Liccardo D; Zincarelli C; de Lucia C; Pagano G; Komici K; Parisi V; Scala O; Agresta A; Rapacciuolo A; Perrone Filardi P; Ferrara N; Koch WJ; Trimarco B; Femminella GD; Leosco D
    Circ Heart Fail; 2013 Nov; 6(6):1259-67. PubMed ID: 24029661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice.
    Xiang FL; Lu X; Hammoud L; Zhu P; Chidiac P; Robbins J; Feng Q
    Circulation; 2009 Sep; 120(12):1065-74, 9 p following 1074. PubMed ID: 19738140
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mesenchymal stem cells participate in angiogenesis and improve heart function in rat model of myocardial ischemia with reperfusion.
    Tang J; Xie Q; Pan G; Wang J; Wang M
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):353-61. PubMed ID: 16829080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Midkine gene transfer after myocardial infarction in rats prevents remodelling and ameliorates cardiac dysfunction.
    Sumida A; Horiba M; Ishiguro H; Takenaka H; Ueda N; Ooboshi H; Opthof T; Kadomatsu K; Kodama I
    Cardiovasc Res; 2010 Apr; 86(1):113-21. PubMed ID: 19969622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IQGAP1, a novel vascular endothelial growth factor receptor binding protein, is involved in reactive oxygen species--dependent endothelial migration and proliferation.
    Yamaoka-Tojo M; Ushio-Fukai M; Hilenski L; Dikalov SI; Chen YE; Tojo T; Fukai T; Fujimoto M; Patrushev NA; Wang N; Kontos CD; Bloom GS; Alexander RW
    Circ Res; 2004 Aug; 95(3):276-83. PubMed ID: 15217908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuron-derived neurotrophic factor ameliorates adverse cardiac remodeling after experimental myocardial infarction.
    Joki Y; Ohashi K; Yuasa D; Shibata R; Kataoka Y; Kambara T; Uemura Y; Matsuo K; Hayakawa S; Hiramatsu-Ito M; Kanemura N; Ito M; Ogawa H; Daida H; Murohara T; Ouchi N
    Circ Heart Fail; 2015 Mar; 8(2):342-51. PubMed ID: 25654972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis.
    Wang Y; Ahmad N; Wani MA; Ashraf M
    J Mol Cell Cardiol; 2004 Nov; 37(5):1041-52. PubMed ID: 15522281
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Mobility Group Box 1 Promotes Angiogenesis from Bone Marrow-derived Endothelial Progenitor Cells after Myocardial Infarction.
    Nakamura Y; Suzuki S; Shimizu T; Miyata M; Shishido T; Ikeda K; Saitoh S; Kubota I; Takeishi Y
    J Atheroscler Thromb; 2015; 22(6):570-81. PubMed ID: 25735431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction.
    Hayashidani S; Tsutsui H; Shiomi T; Ikeuchi M; Matsusaka H; Suematsu N; Wen J; Egashira K; Takeshita A
    Circulation; 2003 Oct; 108(17):2134-40. PubMed ID: 14517168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1.
    Fukuda S; Kaga S; Zhan L; Bagchi D; Das DK; Bertelli A; Maulik N
    Cell Biochem Biophys; 2006; 44(1):43-9. PubMed ID: 16456233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypoxia-induced mitogenic factor enhances angiogenesis by promoting proliferation and migration of endothelial cells.
    Tong Q; Zheng L; Li B; Wang D; Huang C; Matuschak GM; Li D
    Exp Cell Res; 2006 Nov; 312(18):3559-69. PubMed ID: 16982054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats.
    Wang F; Huang D; Zhu W; Li S; Yan M; Wei M; Li J
    Int J Mol Med; 2013 Nov; 32(5):1037-46. PubMed ID: 24002353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
    Lin MT; Yen ML; Lin CY; Kuo ML
    Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced intracellular chloride concentration impairs angiogenesis by inhibiting oxidative stress-mediated VEGFR2 activation.
    Li K; Liu YY; Lv XF; Lin ZM; Zhang TT; Zhang FR; Guo JW; Hong Y; Liu X; Lin XC; Zhou JG; Wu QQ; Liang SJ; Shang JY
    Acta Pharmacol Sin; 2021 Apr; 42(4):560-572. PubMed ID: 32694758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure.
    Banquet S; Gomez E; Nicol L; Edwards-Lévy F; Henry JP; Cao R; Schapman D; Dautreaux B; Lallemand F; Bauer F; Cao Y; Thuillez C; Mulder P; Richard V; Brakenhielm E
    Circulation; 2011 Aug; 124(9):1059-69. PubMed ID: 21824923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular FLICE-inhibitory protein protects against cardiac remodelling after myocardial infarction.
    Xiao J; Moon M; Yan L; Nian M; Zhang Y; Liu C; Lu J; Guan H; Chen M; Jiang D; Jiang H; Liu PP; Li H
    Basic Res Cardiol; 2012 Jan; 107(1):239. PubMed ID: 22202974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.